Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nwosu

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Life Science Alliance|March 30, 2021
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophagesSamantha B Kemp, Nina G Steele, Eileen S Carpenter, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingYujia Li, Chenjun Huang, Weiguo Fan, et al.
Nature Communications|October 17, 2024
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline gliomaNneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to RadiationFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
Cancer & Metabolism|January 8, 2020
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapyBarbara S Nelson, Lin Lin, Daniel M Kremer, et al.
Nature|May 17, 2023
Uridine-derived ribose fuels glucose-restricted pancreatic cancerZeribe C Nwosu, Matthew H Ward, Peter Sajjakulnukit, et al.
Research Square|September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic TargetFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
Elife|July 11, 2022
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental contextSamuel A Kerk, Lin Lin, Amy L Myers, et al.
Cancer Immunology Research|May 28, 2026
Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancerYaqing Zhang, Padma Kadiyala, Wei Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic CancerNina G Steele, Giulia Biffi, Samantha B Kemp, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Life Science Alliance|March 30, 2021
Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophagesSamantha B Kemp, Nina G Steele, Eileen S Carpenter, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signallingYujia Li, Chenjun Huang, Weiguo Fan, et al.
Nature Communications|October 17, 2024
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline gliomaNneka E Mbah, Amy L Myers, Peter Sajjakulnukit, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to RadiationFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
Cancer & Metabolism|January 8, 2020
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapyBarbara S Nelson, Lin Lin, Daniel M Kremer, et al.
Nature|May 17, 2023
Uridine-derived ribose fuels glucose-restricted pancreatic cancerZeribe C Nwosu, Matthew H Ward, Peter Sajjakulnukit, et al.
Research Square|September 18, 2025
Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic TargetFelipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, et al.
Elife|July 11, 2022
Metabolic requirement for GOT2 in pancreatic cancer depends on environmental contextSamuel A Kerk, Lin Lin, Amy L Myers, et al.
Cancer Immunology Research|May 28, 2026
Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancerYaqing Zhang, Padma Kadiyala, Wei Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic CancerNina G Steele, Giulia Biffi, Samantha B Kemp, et al.
Pageof 13